Category: Series
-
Lophos Pharma (MESC.C) now readies for natural and synthetic peyote production
Lophos Pharmaceuticals Corp. (MESC.C), a key player in the Canadian biosciences/psychedelics sector, has made a significant leap forward in the field of psychoactive compound research and development as it has announced the successful finalization of a new synthetic mescaline production protocol, marking a major milestone in the accessibility and study of psychoactive substances. This development…
-
Inflation surprise! US CPI comes in hot at 3.1% in January
Inflation surprise! The contrarians are having their victory lap. With the markets expecting at least three 25 basis point rate cuts this year, the Fed recently disappointed some investors with a reinforcement of their “cautious approach”. Perhaps their slow approach to cutting rates is warranted. The battle against inflation isn’t done just yet. With no…
-
To space and back: Hyperspectral tech to be used in lithium exploration at Lancaster Resources (LCR.C)
When I watch a mining-based TV show like those regularly seen on the Discovery Channel, and some mucky-booted, sun-beaten wanderer busts out their trusty gold pan or their metal detector to see if some patch of ground is worth sticking a hole in, I’m always struck by how mining technology hasn’t changed all that much…
-
The Fed to take a slow approach in cutting rates
The theme for 2024? Rate cuts. Central banks are widely expected to cut interest rates this year. However, how many cuts is the big debate. Oh and now when those cuts will happen. The contrarians out there are celebrating as they have said that the economy needs to take a dip to justify rate cuts.…
-
LQR House (LQR.Q) puts involuntary hold on 1/3 of float, calls it a ‘dividend’
Liquor e-commerce platform LQR House (LQR.Q) made a bold but carefully worded announcement in January of this year that seemed like one of the greatest deals ever. A $1 per share dividend. LQR House Inc., a niche e-commerce platform specializing in the spirits and beverage industry, is pleased to announce that the Company’s Board of…
-
Revive Therapeutics (RVV.C) takes on long covid with new phase 2/3 FDA protocol
Allow me to back into the lede a bit here. THE STORY OF ROCKERFELLER VS THE WORMS In the early part of the 20th century, the American South was known colloquially as ‘the hookworm belt.’ Hookworms are parasites that like a human host. They corkscrew into your feet when you walk by them barefoot, travel…
-
Peyote at the ready: Lophos Holdings (MESC.C) expands license, lays out product specs
What a time to be alive; there was a period in our civilized history where getting alcohol on a Sunday was a tough racket, now we’re exploring the safe supply of cocaine, goverment sold weed, prescribed MDMA, magic mushroom microdosing and, increasingly, the wondrous powers of peyote being safely available to those who partake. It…
-
Why I am buying Japan
So I feel validated, folks. Regular readers know that I have been covering Japan, and what I believe is a great opportunity for investors. Yes you heard that right. Japan is a great opportunity in 2024. Last weekend, we had the Vancouver Resource Investment Conference. The final panel was about major investment opportunities. I heard…